Alternative splicing in tumour viruses: a therapeutic target?

Hernandez-Lopez, H. and Graham, S. (2012) Alternative splicing in tumour viruses: a therapeutic target? Biochemical Journal, 445, pp. 145-156. (doi: 10.1042/BJ20120413) (PMID:22738337)

Full text not currently available from Enlighten.

Abstract

Persistent infection with cancer risk-related viruses leads to molecular, cellular and immune response changes in host organisms that in some cases direct cellular transformation. Alternative splicing is a conserved cellular process that increases the coding complexity of genomes at the pre-mRNA processing stage. Human and other animal tumour viruses use alternative splicing as a process to maximize their transcriptomes and proteomes. Medical therapeutics to clear persistent viral infections are still limited. However, specific lessons learned in some viruses (e.g. human immunodeficiency virus (HIV) and hepatitis C virus (HCV)) suggest that drug-directed inhibition of alternative splicing could be useful for this purpose. This review describes the basic mechanisms of constitutive and alternative splicing in a cellular context and known splicing patterns and the mechanisms by which these might be achieved for the major human-infective tumour viruses. The roles of splicing-related proteins expressed by these viruses in cellular and viral gene regulation are explored. Moreover, we discuss some currently available drugs targeting serine-arginine-rich SR proteins that are the main regulators of constitutive and alternative splicing, and their potential use in treatment for so-called persistent viral infections.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Graham, Professor Sheila
Authors: Hernandez-Lopez, H., and Graham, S.
Subjects:Q Science > QR Microbiology > QR355 Virology
College/School:College of Medical Veterinary and Life Sciences > School of Infection & Immunity
College of Medical Veterinary and Life Sciences > School of Infection & Immunity > Centre for Virus Research
Journal Name:Biochemical Journal
Journal Abbr.:Biochem. J.
Publisher:Portland Press Ltd.
ISSN:0264-6021
ISSN (Online):1470-8728
Published Online:27 June 2012

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
507841Human papillomavirus E2 regulation of splicing factors: consequences for the virus life cycleSheila GrahamWellcome Trust (WELLCOME)088848/Z/09/ZCentre for Virus Research